Evaluation of Cardiovascular Risk Factors, Haematological and Biochemical Parameters, and Serum Endocan Levels in

Emin Ozlu1, Ayse Serap Karadag, Aybala E Toprak

  • 1Department of Dermatology, Kayseri Training and Research Hospital, Kayseri, Turkey.

Dermatology (Basel, Switzerland)
|August 11, 2016
PubMed

Insights

Serum endocan levels are unchanged in lichen planus (LP) patients. However, LP patients show distinct differences in specific haematological and biochemical parameters compared to healthy individuals.

Area of Science:

  • Dermatology
  • Cardiovascular Medicine
  • Hematology

Background:

  • Lichen planus (LP) is an inflammatory condition with potential systemic implications.
  • Cardiovascular risk factors and specific biomarkers are increasingly studied in relation to LP.
  • Endocan, a potential biomarker, has not been extensively evaluated in LP patients.

Purpose of the Study:

  • To investigate cardiovascular risk factors, haematological and biochemical profiles, and serum endocan levels in lichen planus (LP) patients.
  • To compare these parameters between LP patients and healthy controls.

Main Methods:

  • A case-control study involving 43 LP patients and 43 healthy controls.
  • Evaluation of cardiovascular risk factors, routine haematological and biochemical parameters.
  • Measurement of serum endocan concentrations.

Main Results:

  • Serum endocan concentrations did not significantly differ between LP patients and controls (p > 0.05).
  • No significant differences in endocan levels were observed based on cardiovascular risk factors or smoking history.
  • LP patients exhibited significantly higher white blood cell count, platelet distribution width, and monocyte count/HDL cholesterol ratios compared to controls (p < 0.05).
  • Mean platelet volume was significantly lower in the LP group (p < 0.05).

Conclusions:

  • Serum endocan levels are not significantly altered in lichen planus.
  • Significant differences in specific haematological parameters (WBC, PDW, MPV, and monocyte/HDL ratio) are noted in LP patients.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
688
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
704
Assessment of the Cardiovascular System II: Inspection01:29

Assessment of the Cardiovascular System II: Inspection

Inspection is the initial step in assessing the cardiovascular system. It involves a detailed visual examination that provides crucial information about a patient's circulatory and cardiac health. This systematic process, conducted from head to toe, helps identify signs of cardiovascular conditions by observing physical appearance, skin and mucous membranes, jugular and carotid pulsations, chest symmetry, and the condition of the extremities.
Head and Neck
1.1K
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
526
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
1.0K
Assessment of the Cardiovascular System III: Palpation01:27

Assessment of the Cardiovascular System III: Palpation

Palpation involves feeling the body to evaluate texture, size, consistency, and tenderness for assessing cardiovascular health. The following steps are organized in a head-to-toe order:
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above...
1.4K